MCB holder plans Rule 144 sale of 4,445 shares

Metropolitan Commercial Bank (symbol: MCB) has a shareholder planning to sell common stock under SEC Rule 144.

Rhea-AI Filing Summary

Metropolitan Commercial Bank (symbol: MCB) has a shareholder planning to sell common stock under SEC Rule 144. The notice covers a proposed sale of 4,445 shares of common stock through J.P. Morgan Securities LLC on the NYSE, with an aggregate market value of 422,053. The issuer has 10,298,002 shares of common stock outstanding.

The seller previously acquired 1,111 shares on 05/21/2015 and 3,334 shares on 12/31/2011 through open-market purchases paid in cash. Over the past three months, The Robert C Patent Declaration of Trust sold 10,000 common shares for gross proceeds of 949,929. By signing the notice, the seller represents that they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for MCB disclose?

The Form 144 filing for MCB discloses that a shareholder intends to sell 4,445 shares of Metropolitan Commercial Bank common stock under SEC Rule 144, using J.P. Morgan Securities LLC as broker on the NYSE.

How many MCB shares are planned to be sold and at what market value?

The notice covers a planned sale of 4,445 common shares of MCB with an aggregate market value of 422,053 as shown in the filing’s securities information table.

How many Metropolitan Commercial Bank shares are outstanding?

The filing states that the issuer has 10,298,002 shares of common stock outstanding, providing context for the size of the planned Rule 144 sale.

How and when were the MCB shares in this Form 144 acquired?

The securities to be sold were acquired through open-market purchases, including 1,111 shares on 05/21/2015 and 3,334 shares on 12/31/2011, both paid in cash according to the acquisition table.

What MCB share sales occurred in the past three months by this seller?

The filing lists that The Robert C Patent Declaration of Trust sold 10,000 common shares of MCB on 01/22/2026 for gross proceeds of 949,929 during the past three months.

What representation does the seller make about MCB’s information?

By signing the notice, the person for whose account the securities are to be sold represents that they do not know of any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/23/2026 - 04:02 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001008343
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Metropolitan Bank Holding Corp
SEC File Number	001-38282
Address of Issuer	99 Park Avenue New York NEW YORK 10016
Phone	212-659-0600
Name of Person for Whose Account the Securities are To Be Sold	Robert C Patent
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	J.P. Morgan Securities LLC 270 Park Avenue, 10th Floor New York NY 10017	4445	422053	10298002	01/23/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	05/21/2015	Open Market Purchase	See Nature of Acquisition			1111	05/21/2015	Cash
Common Stock	12/31/2011	Open Market Purchase	See Nature of Acquisition			3334	12/31/2011	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
The Robert C Patent Declaration of Trust 99 Park Avenue New York NY 10016	Common	01/22/2026	10000	949929

144: Remarks and Signature

Remarks	The shares filed today will be sold by The Robert C Patent Declaration of Trust, Robert C. Patent as Trustee
Date of Notice	01/23/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Robert C. Patent.
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)